Effectiveness of Atypical Versus Conventional Antipsychotics in Treating Schizophrenia
Effectiveness of Atypical Vs Conventional Antipsychotics
2 other identifiers
interventional
N/A
0 countries
N/A
Brief Summary
This study will compare the effectiveness of newer atypical antipsychotics versus older conventional antipsychotics in treating schizophrenia.
Trial Health
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Primary Completion
Last participant's last visit for primary outcome
December 1, 2002
CompletedFirst Submitted
Initial submission to the registry
October 7, 2005
CompletedFirst Posted
Study publicly available on registry
October 12, 2005
CompletedJune 6, 2014
June 1, 2014
October 7, 2005
June 5, 2014
Conditions
Outcome Measures
Primary Outcomes (2)
PANSS
Retention.
Secondary Outcomes (1)
EPS, TD.
Interventions
Eligibility Criteria
You may qualify if:
- hospitalized for schizophrenia
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yale Universitylead
- National Institute of Mental Health (NIMH)collaborator
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Scott W Woods, MD
Yale University
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 7, 2005
First Posted
October 12, 2005
Primary Completion
December 1, 2002
Last Updated
June 6, 2014
Record last verified: 2014-06